Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hicks

Showing results (1181-1190 of 1,277) with videos related to

Pageof 128
Sort By:
Oncogene|June 22, 2010
Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastomaX Shang, S A Vasudevan, Y Yu, et al.
The Journal of Pathology|April 4, 2017
Cousins not twins: intratumoural and intertumoural heterogeneity in syndromic neuroendocrine tumoursAidan Flynn, Trisha Dwight, Diana Benn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2019
Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of <sup>177</sup>Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate CancerJohn Violet, Shahneen Sandhu, Amir Iravani, et al.
Journal of Medicinal Chemistry|July 16, 2015
Synthesis and in Vivo Evaluation of [123I]Melanin-Targeted AgentsMaxine P Roberts, Vu Nguyen, Mark E Ashford, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 17, 2021
Neutrophil-Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell Lung CancerA Punjabi, E Barrett, A Cheng, et al.
Science (New York, N.Y.)|July 22, 2010
Association of trypanolytic ApoL1 variants with kidney disease in African AmericansGiulio Genovese, David J Friedman, Michael D Ross, et al.
Kidney International|June 11, 2018
Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactionsCarl D Langefeld, Mary E Comeau, Maggie C Y Ng, et al.
British Journal of Cancer|October 17, 2014
A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcomaJ Lewin, K K Khamly, R J Young, et al.
Cancer Discovery|July 17, 2012
BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitorsKimberly Brown Dahlman, Junfeng Xia, Katherine Hutchinson, et al.
International Journal of Technology Assessment in Health Care|December 25, 2009
The HTA core model: a novel method for producing and reporting health technology assessmentsKristian Lampe, Marjukka Mäkelä, Marcial Velasco Garrido, et al.
Pageof 128

Showing results (1181-1190 of 1,277) with videos related to

Sort By:
Pageof 128
Oncogene|June 22, 2010
Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastomaX Shang, S A Vasudevan, Y Yu, et al.
The Journal of Pathology|April 4, 2017
Cousins not twins: intratumoural and intertumoural heterogeneity in syndromic neuroendocrine tumoursAidan Flynn, Trisha Dwight, Diana Benn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2019
Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of <sup>177</sup>Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate CancerJohn Violet, Shahneen Sandhu, Amir Iravani, et al.
Journal of Medicinal Chemistry|July 16, 2015
Synthesis and in Vivo Evaluation of [123I]Melanin-Targeted AgentsMaxine P Roberts, Vu Nguyen, Mark E Ashford, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 17, 2021
Neutrophil-Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell Lung CancerA Punjabi, E Barrett, A Cheng, et al.
Science (New York, N.Y.)|July 22, 2010
Association of trypanolytic ApoL1 variants with kidney disease in African AmericansGiulio Genovese, David J Friedman, Michael D Ross, et al.
Kidney International|June 11, 2018
Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactionsCarl D Langefeld, Mary E Comeau, Maggie C Y Ng, et al.
British Journal of Cancer|October 17, 2014
A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcomaJ Lewin, K K Khamly, R J Young, et al.
Cancer Discovery|July 17, 2012
BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitorsKimberly Brown Dahlman, Junfeng Xia, Katherine Hutchinson, et al.
International Journal of Technology Assessment in Health Care|December 25, 2009
The HTA core model: a novel method for producing and reporting health technology assessmentsKristian Lampe, Marjukka Mäkelä, Marcial Velasco Garrido, et al.
Pageof 128